Fenbendazole (Panacur, Safe-Guard) is a veterinary drug used to treat parasites in animals. It has not been approved by the FDA to treat cancer in humans. However, many cancer patients report success using the fenbendazole protocol, which is often “off label” (meaning that the drug’s normal use has not been approved). If you want to try the fenbendazole cancer protocol, be sure to follow your veterinarian’s directions and precautions closely. In particular, it is important to get regular blood tests to monitor liver enzymes and ensure that the dose is working properly.
The fenbendazole medication works by blocking the formation of microtubules in the parasite cells. This causes the cell to break apart and die. It is also thought to reduce the growth of tumors by inhibiting the movement of cancerous cells in the body. This is why it is often used along with other anti-cancer treatments, such as radiation and chemotherapy.
The fenbendazole cancer protocol has gained popularity in recent years due to the reports of people who have been successfully treated with it. There is also research that supports the effectiveness of this approach. In one study, researchers found that fenbendazole slows the growth of tumors in mice. However, results vary between different species and the effectiveness of this treatment may depend on other factors, such as a patient’s age. Despite this, some scientists are continuing to explore the potential of fenbendazole for cancer therapy in humans. fenbendazole 222mg capsules for humans